EMERYVILLE, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. today announced that it will present at the Biotechnology Industry Organization (BIO) CEO & Investor conference on Tuesday, February 14, at 11:30 a.m. Eastern Time. Interested parties may access a live webcast of the presentation at:
http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=ONXX&item_id=1211541
It is recommended that listeners log on 15 minutes early in order to register and download any necessary software. For those unable to participate during the live webcast, a recorded replay of the presentation will be available within 24 hours of the completion of the presentation through March 14, 2006.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including Nexavar(R) (sorafenib) tablets with Bayer Pharmaceuticals Corporation. For more information about Onyx’s pipeline and activities, visit the company’s website at www.onyx-pharm.com.
NOTE: Nexavar(R) (sorafenib) tablets is a registered trademark of Bayer Pharmaceuticals Corporation.
Onyx Pharmaceuticals, Inc.
CONTACT: Julie Wood, +1-510-597-6505, or Alexandra Santos,+1-510-597-6504, both of Onyx Pharmaceuticals, Inc.
Web site: http://www.onyx-pharm.com/
